Esco Lifesciences’ US$200 Million Series A Financing

Sidley Austin LLP advised Vivo Capital and Novo Holdings A/S as lead investors on the deal, while Davis Polk advised Esco Lifesciences. Vivo Capital and Novo…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now